Almac Dx Serving as Sole Reference Lab for Exonhit's Test for Alzheimer's | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exonhit today said that Almac Diagnostics will serve as the sole reference laboratory for testing performed with Exonhit's AclarusDx for Alzheimer's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.